PLA2G3 anticorps (Internal Region)

N° du produit ABIN2469549

Cet anticorps anti-PLA2G3 est un anticorps Lapin Polyclonal détectant PLA2G3 dans IHC. Adapté pour Humain, Boeuf (Vache), Singe, Porc, Gibbon et Gorilla.

Aperçu rapide pour PLA2G3 anticorps (Internal Region) (ABIN2469549)

Antigène: PLA2G3 (Phospholipase A2, Group III (PLA2G3))

Reactivité: Humain, Boeuf (Vache), Singe, Porc, Gibbon, Gorilla

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp PLA2G3 est non-conjugé

Application: Immunohistochemistry (IHC)

Détail du produit anti-PLA2G3 anticorps

Épitope: Internal Region

Specificité: BLAST analysis of the peptide immunogen showed no homology with other human proteins.

Purification: Immunoaffinity Chromatography

Immunogène: PLA2G3 antibody was raised against a peptide located near the internal domain of PLA2G3 (Human).

Information d'application

Indications d'application: PLA2G3 antibody can be used in ELISA, and immunohistochemistry starting at 10 μg/mL.

Restrictions: For Research Use only

Stockage

Format: Liquid

Buffer: PBS, 0.1 % sodium azide.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: As with all antibodies avoid freeze/thaw cycles.

Stock: 4 °C/-80 °C

Stockage commentaire: PLA2G3 antibody should be stored long term (months) at -80 °C and short term (days) at 4 °C.

Détails sur PLA2G3

Antigène: PLA2G3 (Phospholipase A2, Group III (PLA2G3))

Autre désignation: PLA2G3

Sujet: Human group III secreted phospholipase A2 belongs to a superfamily of intracellular and secreted enzymes that catalyze the hydrolysis of glycerophospholipids at the sn-2 position to release fatty acids and lysophospholipids. Group III PLA2 enzymes were originally identified in invertebrates such as bees and scorpions. Human group III sPLA2 has been shown to be a calcium dependent enzyme. It consists of a central group III sPLA2 domain flanked by unique N- and C-terminal domains that are proteolytically removed in most tissues. The sPLA2 domain is sufficient for catalytic activity. SPLA2-III is preferentially expressed in the microvascular endothelium of tissues with inflammation, ischemic injury and cancer.

ID gène: 50487

UniProt: Q9NZ20